Quoin Pharmaceuticals Ltd. SEC filings QNRX
Quoin Pharmaceuticals Ltd. has 583 filings in SEC EDGAR's recent list, going back to Apr 8, 2016. Its latest annual report, Form ARS, was filed on Jul 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement).
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| EFFECT | Filing | Nov 4, 2026 | — |
| 8-K |
Current report
Material agreement
|
Nov 4, 2026 | Nov 4, 2026 |
| 424B5 | Prospectus supplement | Nov 4, 2026 | — |
| 424B5 | Prospectus supplement | Nov 4, 2026 | — |
| S-3 | Shelf registration | Oct 28, 2026 | — |
| 4/A | Ownership document | Oct 26, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 20, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 14, 2026 | Oct 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 7, 2026 | — |
| DEF 14A | Proxy statement | Oct 2, 2026 | Nov 12, 2026 |
| EFFECT | Filing | Sep 25, 2026 | — |
| 424B3 | Prospectus | Sep 25, 2026 | — |
| PRE 14A | Preliminary proxy statement | Sep 22, 2026 | Nov 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 22, 2026 | Sep 22, 2026 |
| S-3 | Shelf registration | Sep 18, 2026 | — |
| D | Filing | Sep 10, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 10, 2026 | Sep 8, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Aug 28, 2026 | Aug 27, 2026 |
| 4 | Insider transaction | Aug 28, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Aug 28, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Aug 20, 2026 | Aug 20, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| ARS | Annual report to shareholders | Jul 16, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Jul 16, 2026 | Aug 20, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 6, 2026 | Aug 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 23, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 4, 2026 | Jun 4, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 2, 2026 | — |
| 424B3 | Prospectus | Jun 2, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 29, 2026 | — |
| 4 | Insider transaction | Mar 31, 2026 | Mar 26, 2026 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 11, 2026 | Mar 11, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 11, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 6, 2026 | — |
| 4 | Insider transaction | Feb 6, 2026 | Feb 4, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 4, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 4, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 4, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 4, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 4, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 4, 2026 |
| 4 | Insider transaction | Feb 6, 2026 | Feb 4, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 2, 2026 | — |
| 3 | Initial insider ownership | Feb 2, 2026 | Jan 29, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 28, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 20, 2026 | Jan 20, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 16, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 11, 2025 | — |
| 424B3 | Prospectus | Dec 5, 2025 | — |
| EFFECT | Filing | Dec 4, 2025 | — |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| CORRESP | Letter to the SEC | Dec 2, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Nov 17, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 12, 2025 | Nov 11, 2025 |
| S-3 | Shelf registration | Nov 7, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2025 | — |
| D | Filing | Oct 23, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 21, 2025 | Oct 21, 2025 |
| 4 | Insider transaction | Oct 15, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 15, 2025 | Oct 10, 2025 |
| 3 | Initial insider ownership | Sep 8, 2025 | Aug 18, 2025 |
| S-8 | Employee stock plan registration | Aug 27, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2025 | Aug 21, 2025 |
| S-8 | Employee stock plan registration | Aug 25, 2025 | — |
| 4 | Insider transaction | Aug 25, 2025 | Aug 21, 2025 |
| 4 | Insider transaction | Aug 25, 2025 | Aug 21, 2025 |
| 4 | Insider transaction | Aug 25, 2025 | Aug 21, 2025 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Shareholder vote results, Regulation FD disclosure, Other events
|
Aug 21, 2025 | Aug 15, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| ARS | Annual report to shareholders | Jul 17, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Jul 17, 2025 | Aug 21, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2025 | Jul 3, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 7, 2025 | Aug 21, 2025 |
| 8-K |
Current report
Other events
|
Jun 25, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Other events
|
Jun 20, 2025 | Jun 18, 2025 |
| 4/A | Ownership document | Jun 13, 2025 | May 29, 2025 |
| 4/A | Ownership document | Jun 13, 2025 | May 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 4 | Insider transaction | Jun 2, 2025 | May 29, 2025 |
| 8-K |
Current report
Other events
|
May 23, 2025 | May 22, 2025 |
| 8-K |
Current report
Other events
|
May 21, 2025 | May 20, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
Apr 30, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Change to shareholder rights
|
Apr 4, 2025 | Apr 4, 2025 |
| 8-K |
Current report
Change to shareholder rights
|
Apr 4, 2025 | Apr 4, 2025 |
| EFFECT | Filing | Apr 3, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 2, 2025 | Apr 2, 2025 |
| POS AM | Filing | Mar 28, 2025 | — |
| 8-K |
Current report
Auditor change
|
Mar 20, 2025 | Mar 18, 2025 |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Other events
|
Feb 27, 2025 | Feb 27, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 4, 2025 | Feb 4, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 28, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 28, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 23, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Other events
|
Jan 16, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Other events
|
Jan 6, 2025 | Jan 6, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Jan 2, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Jan 2, 2025 | — |
| 4 | Insider transaction | Dec 27, 2024 | Dec 23, 2024 |
| 4 | Insider transaction | Dec 27, 2024 | Dec 23, 2024 |
| 4 | Insider transaction | Dec 27, 2024 | Dec 23, 2024 |
| 4 | Insider transaction | Dec 27, 2024 | Dec 23, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 26, 2024 | Dec 20, 2024 |
| 424B4 | Prospectus | Dec 23, 2024 | — |
| EFFECT | Filing | Dec 20, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 19, 2024 | Dec 19, 2024 |
| S-1/A | Amended registration statement | Dec 18, 2024 | — |
| CORRESP | Letter to the SEC | Dec 17, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 17, 2024 | — |
| S-1 | Registration statement | Dec 11, 2024 | — |
| 424B3 | Prospectus | Dec 11, 2024 | — |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Shareholder vote results, Other events
|
Dec 10, 2024 | Dec 5, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 424B3 | Prospectus | Nov 8, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 8, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Listing notice
|
Oct 31, 2024 | Oct 29, 2024 |
| DEF 14A | Proxy statement | Oct 24, 2024 | Dec 5, 2024 |
| ARS | Annual report to shareholders | Oct 24, 2024 | Dec 31, 2023 |
| PRE 14A | Preliminary proxy statement | Oct 11, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Other events
|
Sep 30, 2024 | Sep 27, 2024 |
| 4 | Insider transaction | Sep 11, 2024 | Sep 9, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 8, 2024 |
| 424B3 | Prospectus | Aug 12, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 144 | Notice of proposed sale | Jun 7, 2024 | — |
| 424B3 | Prospectus | May 10, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 424B3 | Prospectus | May 8, 2024 | — |
| 8-K |
Current report
Listing notice
|
May 3, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Apr 9, 2024 | Apr 5, 2024 |
| EFFECT | Filing | Apr 3, 2024 | — |
| DEFA14A | Additional proxy material | Apr 2, 2024 | — |
| POS AM | Filing | Mar 29, 2024 | — |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2024 | Mar 13, 2024 |
| 424B3 | Prospectus | Mar 8, 2024 | — |
| 424B3 | Prospectus | Mar 8, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 8, 2024 | Mar 4, 2024 |
| 424B4 | Prospectus | Mar 6, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 6, 2024 | Feb 29, 2024 |
| 424B3 | Prospectus | Mar 4, 2024 | — |
| DEF 14A | Proxy statement | Feb 27, 2024 | Mar 29, 2024 |
| EFFECT | Filing | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2024 | — |
| S-1/A | Amended registration statement | Feb 13, 2024 | — |
| PRE 14A | Preliminary proxy statement | Feb 13, 2024 | Mar 29, 2024 |
| S-1 | Registration statement | Feb 12, 2024 | — |
| 424B3 | Prospectus | Jan 31, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 30, 2024 | Jan 25, 2024 |
| 424B3 | Prospectus | Dec 18, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 18, 2023 | Dec 13, 2023 |
| 424B3 | Prospectus | Nov 9, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 8, 2023 |
| 424B3 | Prospectus | Nov 7, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QNRX (Nasdaq)
- Incorporated in
- Israel
- Headquarters
- Ashburn, VA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1671502
- Former names
- Quoin Pharmaceuticals, Ltd. (until Sep 1, 2026); Cellect Biotechnology Ltd. (until Oct 15, 2021); Cellect Biomed Ltd. (until Jul 7, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.